U.S. markets closed

Pharmadrug Inc. (LMLLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0689+0.0010 (+1.47%)
At close: 3:28PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0679
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0535 - 0.0707
52 Week Range0.0021 - 0.1300
Avg. Volume231,202
Market Cap12.568M
Beta (5Y Monthly)3.86
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • CNW Group

      IIROC Trade Resumption - BUZZ

      VANCOUVER, BC, Jan. 12, 2021 /CNW/ - Trading resumes in:Company: Pharmadrug Inc.

    • PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

      PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

      Toronto, Ontario--(Newsfile Corp. - January 12, 2021) -  PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it has entered into a binding letter of intent (the "LOI"), dated January 11, 2021, to acquire Sairiyo Therapeutics Inc. ("Sairiyo") (the "Acquisition"). Sairiyo is a biotechnology ...

    • CNW Group

      IIROC Trading Halt - BUZZ

      VANCOUVER, BC, Jan. 11, 2021 /CNW/ - The following issues have been halted by IIROC:Company: Pharmadrug Inc.